NCT05770895 Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B Status COMPLETED Phase PHASE1
NCT05769816 A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A) Status RECRUITING Phase PHASE2
NCT05766449 Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD Status RECRUITING Phase N/A
NCT05763576 A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7565020 in Healthy Participants and in Participants With Chronic Hepatitis B Virus Infection Status TERMINATED Phase PHASE1
NCT05760781 To Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B Status TERMINATED Phase PHASE2
NCT05760703 Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B Status TERMINATED Phase PHASE2
NCT05755776 The Efficacy and Safety of Tenofovir Amibufenamide to Treat Low-level Viraemia After Entecavir Treatment Status UNKNOWN Phase N/A
NCT05753280 Effect of Serum Vitamin D Level on the Efficacy of Peg-interferon Treatment in CHB Status COMPLETED Phase PHASE4
NCT05727267 A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate Status RECRUITING Phase PHASE1
NCT05721300 Study on Screening, Verification and Intervention of High-risk Patients With Liver Cancer Status UNKNOWN Phase NA
NCT05717686 A Study Evaluating AHB-137 in Healthy Participants and Participants with Chronic Hepatitis B Status COMPLETED Phase PHASE1
NCT05705141 The Effect of Metabolic Syndrome on Antiviral Response in People With Chronic Hepatitis B Status NOT_YET_RECRUITING Phase N/A
NCT05671315 A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients Status RECRUITING Phase NA
NCT05661786 Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase Status RECRUITING Phase N/A
NCT05637541 Evaluation of The Safety, Efficacy and Pharmacokinetic Characteristics of GST-HG141 Tablets Status COMPLETED Phase PHASE2
NCT05630820 Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2) Status COMPLETED Phase PHASE3
NCT05630807 Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1) Status COMPLETED Phase PHASE3
NCT05569941 A First in Human Study to Assess Safety, Tolerability, Pharmacokinetics of ABI-4334 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT05561530 A Study of ALG-125755 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single Doses in Healthy Volunteers, and Single and Multiple Doses in CHB Subjects Status TERMINATED Phase PHASE1
NCT05523648 Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD Status COMPLETED Phase EARLY_PHASE1